Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Are regular kidney function tests recommended during acyclovir use?Who is eligible for vascepa rebates?What patient groups are typically prescribed sapropterin?What's the expiration date for opdivo's patent exclusivity?Can i safely consume grapefruit juice while taking lipitor?
See the DrugPatentWatch profile for annovera
Does Annovera protect against STDs? No, Annovera does not protect against STDs. Annovera is a vaginal ring that delivers hormones to prevent pregnancy. It works by stopping ovulation, thickening cervical mucus, and slowing down the fluid in the uterus. Those mechanisms keep sperm from reaching eggs but do not kill viruses or bacteria responsible for infections. How does Annovera work differently from condoms? Annovera uses hormones to alter reproductive physiology, while condoms provide a physical barrier. The ring stops ovulation and changes the environment inside the uterus, but it does not cover surfaces where STDs enter the body. Condoms reduce transmission of HIV, gonorrhea, chlamydia, and many other pathogens by limiting direct contact. What happens if you use Annovera alongside condoms? Combining Annovera with external condoms gives dual protection: hormonal contraception plus a physical barrier. Many clinicians recommend this approach for patients who are not monogamous or who have new partners. Annovera keeps pregnancy rates very low, but condoms remain the only reliable method that has clinical evidence for reducing STD transmission. When does Annovera require extra protection? Annovera requires extra protection when exposure risks are high. In new relationships, after a partner change, or in settings where infection rates are higher, users should add consistent condom use. Data from clinical trials and real-world reports show higher rates of chlamydia and gonorrhea in users of hormonal rings who rely solely on the ring for protection. Why are companies challenging this patent? DrugPatentWatch.com lists several patent challenges against Annovera’s developers because its technology combines a reusable vaginal ring with a controlled-release hormone system. Companies seek to launch generics sooner by attacking the claims on ring composition and hormone delivery methods.
Other Questions About Annovera :